Big-Name Drugs Try New Roles In Rheumatism
This article was originally published in The Pink Sheet Daily
Lilly’s Cymbalta performs well in major osteoarthritis trial.
You may also be interested in...
If approved for fibromyalgia and chronic pain, drug label would include six indications.
Second indication comes with news of Repligen settlement.
Tumor necrosis factor inhibitor an important option to Wyeth’s Enbrel, Abbott tells “The Pink Sheet” DAILY.